Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports
Go Back
View Our Subscription Options

Search

Descriptive Alt Text

Filters

Showing results 3,305–3,312 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Pfizer Inc. PADCEV (enfortumab vedotin) - (EV-202) Solid tumors, non-squamous and squamous non–small cell lung cancer Phase 2 Ongoing Intravenous Oncology
Pfizer Inc. Nurtec ODT (rimegepant) Refractory trigeminal neuralgia Phase 2 Trial Completed Oral Neurology
Pfizer Inc. ARV-471 with IBRANCE (palbociclib) - (TACTIVE-N) ER+ positive / HER2- negative breast cancer Phase 2 Data Released Oral Oncology
Pfizer Inc. Troriluzole Alzheimer’s disease Phase 2 Trial Discontinued Oral Neurology
Pfizer Inc. GBT440 Hypoxemia in patients with idiopathic pulmonary fibrosis (IPF) who are on supplemental oxygen at rest Phase 2a Trial Discontinued Oral Respiratory
PharmaCyte Biotech Inc. CypCaps Pancreatic cancer Phase 2b Oral Oncology
PharmaTher Holdings Ltd 3,4-Methylenedioxy​methamphetamine (MDMA) with MN-Patch Post traumatic stress disorder (PTSD) NDA Filing Ongoing Transdermal Psychiatric
PharmaTher Holdings Ltd Ketamine Levodopa-induced dyskinesia (LID-PD) in patients with Parkinson's disease Phase 3 Trial Planned Intravenous Intramuscular Oral Nasal Rectal Subcutaneous Neurology
1…412413414415416…553
Your trusted source for drug reimbursement data and buy-and-bill insights.
Platform
Resources
Tools
Search Drugs
Newsletter
Reimbursement updates, drug pricing news.
© 2026 BuyandBill.com, All Rights Reserved.
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, America's Health Insurance Plans, and Blue Cross and Blue Shield Association). CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.